Zobrazeno 1 - 10
of 114
pro vyhledávání: '"H, SANSARRICQ"'
Autor:
C. M. Bannerjee
Publikováno v:
The Indian Journal of Pediatrics. 43:388-388
Autor:
H, Sansarricq, D, Daumerie
Publikováno v:
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 69(2)
Autor:
H, Sansarricq
Publikováno v:
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 67(1)
Autor:
S K, Noordeen, M G, Roxas, P E, Fine, W C, Smith, P, Feenstra, S D, Gokhale, L K, Joo, L, Huan-Ying, G, Khalafalla, M, Becx-Bleumink, H, Srinivasan, C K, Rao, M F, Lechat, H, Sansarricq
Publikováno v:
World health forum. 17(2)
Systematic use of multidrug therapy has proved to be so effective that leprosy can be eliminated as a public health problem by the end of the century. However, because of the long incubation period of this disease, together with the time-lag in case
Autor:
H, Sansarricq
Publikováno v:
Acta leprologica. 10(1)
Autor:
M, Constant-Desportes, C C, Guelpa-Lauras, J C, Carolina, A, Léoture, J H, Grosset, H, Sansarricq
Publikováno v:
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 59(2)
A male born in 1930 was diagnosed as smear-positive borderline leprosy in 1971, and was treated with dapsone and/or sulfamethoxypyridazine from 1972 to 1980 with clinical improvement. However, new skin lesions with smears strongly positive appeared i
Autor:
Diana, D., Harish, M. C.
Publikováno v:
Frontiers in Molecular Biosciences; 2024, p1-13, 13p
Publikováno v:
Leprosy review. 55(4)
Autor:
K, Lwin, T, Sundaresan, M M, Gyi, L M, Bechelli, C, Tamondong, P G, Garbajosa, H, Sansarricq, S K, Noordeen
Publikováno v:
Bulletin of the World Health Organization. 63(6)
The value of BCG vaccination in preventing leprosy among children was studied in an area of high leprosy endemicity in Burma through a controlled trial; one group of 13 066 children received BCG and another group of 13 176 served as controls. The ove
Autor:
H, Sansarricq
Publikováno v:
Revue d'epidemiologie et de sante publique. 29(3)
Investigations carried out by the Scientific Working Group on Immunology of Leprosy (IMMLEP) have led to the planning of field trials of an experimental vaccine preparation to be carried out in few years' time. The objectives of these trials have bee